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This paper  rst discusses the developmental origin of IVF (In vitro fer-
tilization) and analyzes the four generations of IVF technology in detail. 
Then, combined with its own work experience, it discusses the neonatal 
situation of IVF, in order to improve reference for other medical staff.
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1. The Development Origin of IVF
T
he research and development of IVF technology 
can be traced back to the middle of the 20th centu-
ry. The original purpose of this kind of assisted re-
productive technology research is to better contraception. 
In this process, people have studied the ovulation cycle 
and inheritance of mammals. The content of learning, 
embryology, etc.,  nally got the key content of the female 
egg cell development cycle. At  rst, the scientists at that 
time speculated that the female egg cell development 
cycle only required a false conclusion of 12h, which led 
to serious obstacles and blows to the in vitro fertilization 
experiment. It was not until 1965 that scholars pointed out 
that human and some mammalian egg cells have a  xed 
developmental time (37h). Subsequently, the application 
and research of gonadotropins in other countries further 
promoted the progress of IVF. Superovulation is induced 
by ovulation drugs, and the control of egg cell matura-
tion time is achieved by using drugs such as clomiphene 
citrate and stimulating hormone, which makes it easier to 
grasp the timing of egg retrieval. This method is called 
controlled superovulation.[1] In addition, advances in egg 
retrieval technology have also played an important role 
in promoting the development of IVF. The use of laparo-
scopic technologys to achieve egg retrieval can reduce the 
trauma caused to women. The appearance of pyruvate has 
effectively improved the effect of in vitro embryo culture 
and greatly promoted the development of IVF technology.
2. The Development History of IVF
In 1978, the world’s  rst IVF baby was born in the UK, 
bringing the gospel to infertility patients. IVF is not really 
a growing baby in a test tube, but is artificially in vitro 
fertilized in the laboratory by taking a large amount of 
ovum from the female ovary. And bred it into an early 
embryo, and then transplanted back to the mother uterus 
at the appropriate time to further develop and grow the 
15
Journal of Advances in Medicine Science | Volume 02 | Issue 02 | April 2019
Distributed under creative commons license 4.0 DOI: https://doi.org/10.30564/jams.v2i2.509
baby. Research on IVF has continued for several decades, 
during which time the development of IVF technology has 
gone through four generations, where the four generations 
of IVF technology are explained in detail.
2.1 First Generation IVF (IVF-ET)
The first generation of IVF includes in vitro fertilization 
and embryo transfer, which is the most basic assisted re-
productive technology for IVF. This technology covers a 
wide range of subjects such as embryology, micromanip-
ulation, and endocrinology, through human intervention. 
The form solves the infertility caused by the problem of 
female uterus endometriosis and tubal occlusion, and real-
izes the reproduction of human beings. At the same time, 
the  rst pregnancy rate of the  rst generation of IVF tech-
nology was less than 3%. With the maturity of biotechnol-
ogy and the improvement of cell nutrient solution, coupled 
with the continuous enrichment of medical staff, the suc-
cess rate of IVF in recent years. Increase to 20% to 30% 
or even higher than the success rate of natural conception. 
The  rst generation of IVF is commonly used in infertility 
caused by female reasons. It has no good solution to male 
problems such as weak, abnormal, and azoless, which is 
also its shortcoming. The  rst IVF baby in mainland China 
was born in 1988 at Peking University Third Hospital.
The IVF technology requires several steps. First, bi-
ological means is required to promote superovulation in 
women, followed by removal of ovum and sperm, in vitro 
fertilization, and embryo transfer after a period of culture. 
In order to improve the success rate of this technology, it 
is necessary to obtain as many healthy and mature ovum 
and a large number of sperm as possible, and after in vi-
tro fertilization, a plurality of embryos are cultured, and 
2 to 3 excellent embryos are implanted from the mother. 
At a time when embryo freezing and thawing technology 
has been widely developed, women can choose this tech-
nology to preserve mature ovum or embryos, so that the 
re-transplantation will not be successful due to the fact 
that the fertilized eggs are not implanted. The success rate 
of the  rst generation of IVF will be affected by maternal 
health status, age and history of abortion and the increase 
in age is inversely proportional to the success rate of IVF
2.2 Second Generation IVF (ICSI)
The academic name of the second generation of IVF is in-
tracytoplasmic sperm injection. Many people think that the 
second generation of IVF is the evolution of the  rst gener-
ation of IVF, which is better than the  rst generation of IVF 
technology. In fact, the second generation of IVF is mainly 
developed for the problem of male sperm fertilization abil-
ity. The second generation of IVF technology is to extract 
sperm from the epididymis, or to obtain sperm through 
testicular tissue sectioning method, and then inject single 
male sperm into the cytoplasm of egg cells by single sperm 
microinjection technology, thereby achieving egg cell fer-
tilization and breeding into embryos. The subsequent steps 
are the same as the  rst generation, so the success rate of 
ICSI technology and IVF technology is not much different. 
Under normal circumstances, the fertilization process of the 
natural physiological state is competitive. Only the sperm 
that undergoes the acrosome reaction can fuse with the egg, 
and the egg membrane is induced to harden to prevent oth-
er sperm from entering. ICSI technology does not have a 
competitive process of sperm, which leads people to worry 
about sperm quality. In 2006, the emergence of PICSI tech-
nology improved this situation. Hyaluronic acid is the main 
component of egg cells, which can screen sperm quality 
and improve the quality of sperm entering the egg cell. The 
PICSI technology refers to the combination of hyaluronic 
acid in a culture dish, the addition of sperm obtained by 
puncture, and subsequent selection of sperm bound to the 
droplets to achieve screening of high-quality sperm. Studies 
have shown that hyaluronic acid can exclude sperm with 
abnormal chromosomes or genes, and DNA strand breaks 
and other conditions appear less, which is conducive to 
promoting sperm maturation. ICSI technology can solve 
the infertility of male weak sperm, abnormality, azoosper-
mia, abnormal sperm acrosome, etc., and promote the ap-
plication of IVF more widely.[2] The second generation of 
IVF was successfully conceived in Belgium in 1992. The 
 rst second-generation IVF in China was born in 1996 at 
Zhongshan Medical University.[3]
2.3 Third Generation IVF (PGD/PGS)
The third generation of IVF is a preimplantation genetic 
diagnosis technology that enables genetic diagnosis and 
screening of in vitro fertilized embryos, selecting the 
highest quality embryos, and preventing the birth of a 
fetus with a genetic defect. The PGD technology mainly 
consists of two steps. One is a biopsy, which refers to the 
aspiration of cells during a part of the embryonic devel-
opment (the cleavage phase and the vesicle phase) to be 
examined; the other is genetic diagnosis, which is a ge-
netic problem such as single-gene genetic disease or chro-
mosomal abnormality by technologys such as polymerase 
chain reaction (PCR) to achieve embryo screening.[4] PGD 
technology can not only solve the problem of infertility, 
but also bring about a major change in improving the 
quality of birth. At the same time, the third generation of 
IVF technology can also analyze the sex of the embryo, 
but in general, Chinese doctors will not inform the sex of 
the fetus, and will only be obliged to inform couples in-
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volved in sexual chromosome diseases. Therefore, China 
has a higher screening requirement for couples applying 
for the third generation of IVF. At present, diseases that 
can be circumvented by PGD technology include cystic 
 brosis, hemophilia A, and myotonic dystrophy. The tech-
nology is still developing, and it is believed that in the 
near future, it will be able to judge more genes and chro-
mosomal diseases and contribute to the improvement of 
China’s reproductive quality.[5]
2.4 Fourth Generation IVF
The fourth generation of IVF is a domestic name for the 
technology of cytoplasmic replacement, and it has also 
become a three-tube IVF technology. Since the chromo-
some in the nucleus is the genetic material of the human 
gene, it plays an important role in determining the genetic 
characteristics of the offspring and maintaining the life ac-
tivities of the cell. The cytoplasmic replacement technolo-
gy refers to the realization of the nucleus replacement be-
tween aging ovum and vigor ovum, forming a new ovum, 
which still expresses the genetic characteristics of aging 
ovum. This technology is mainly applied to older women. 
Because of their older age, if they use their own egg cells, 
they may affect the quality of the embryo. By borrowing 
the follicle cytoplasm of young women, the quality of the 
embryos carrying both husband and wife can be greatly 
improved. The success rate of IVF is increased. However, 
although most of the genetic information of ovum is locat-
ed in the nucleus, there is also human genetic information 
in the cytoplasm of the follicle, and it is also possible to 
write into the genetic sequence of the embryo. Therefore, 
although this technology has been gradually implemented 
in countries such as Japan and the United Kingdom, since 
China is a traditional socialist country, it is very important 
to ethics. This technology is likely to cause serious ethical 
and legal problems, and may also have a serious impact 
on the social atmosphere, so the technology has not been 
promoted and applied in China.
3. The Analysis of IVF Neonatal Conditions
With the development of IVF technology, because IVFs 
usually need to transplant 2~3 embryos during embryo 
transfer to increase the success rate of test tubes as much 
as possible, the IVF rate is higher. At the same time, since 
the embryo needs to be cultured in vitro for a period of 
time after transplantation, the quality of the culture medi-
um in vitro and related environmental factors may affect 
the development of the embryo, which may lead to a low-
er birth weight, perinatal complications, and birth defects 
in IVF neonates than in naturally conceived infants.[6] Rel-
evant scholars at home and abroad pay more attention to 
the birth quality of IVF, and their research conclusions are 
different. Combining my many years of work experience, 
the author summarizes the conditions of newborn birth 
and analyzes the reasons, in order to provide reference for 
other medical staff.
3.1 The Observation Method of Neonatal Condi-
tions
Randomly select 100 newborns of IVF babies who were 
born in our hospital in 2018 and stay in our hospital, as 
well as 100 newborns with natural pregnancy and delivery 
that were born in our hospital and stay in our hospital. Re-
cord in detail the birth status and information, and observe 
and count the indicators such as Apgar score, birth de-
fects, and neonatal complications, and draw conclusions.
3.2 Neonatal Asphyxia
There was no significant difference in neonatal Apgar 
scores, mean weight, hospitalization, neonatal malforma-
tions, and mortality between the single-fetal infants and 
the natural twins. Neonatal asphyxia occurred in only 3 of 
100 single-child single-birth babies, and 10 cases of spon-
taneous births in single-child babies. It can be seen that 
the neonatal asphyxia is mainly due to the hypoxia of the 
mother uterus, hypoxia during labor, or the imperfect lung 
development and insuf cient surfactant.
Because of the hard-won achievements of IVF new-
borns, it is also called precious baby. Pregnant women 
have been strictly pregnant during pregnancy and prenatal 
examination since pregnancy, to prevent all kinds of acci-
dents, so as to effectively prevent uterus hypoxia during 
pregnancy. The situation happened. During the delivery 
of precious baby, the mother is usually hospitalized in 
advance and highly valued by the obstetrician. Once the 
production process is hypoxic, it can be discovered in 
time and properly treated and treated by the doctor. It can 
also effectively prevent neonatal asphyxia. Some pregnant 
women who give birth naturally may not receive system-
atic pregnancy care and prenatal examination, thus losing 
the best time to deal with fetal suffocation. This is also the 
main reason why the neonatal asphyxia rate of IVF babies 
in this hospital is lower than that of natural delivery babies.
3.3 Neonatal Preterm Birth Rate, Hospitalization 
and Birth Weight
Since assisted reproductive technology usually transplants 
multiple embryos to ensure the success rate of IVF, the 
twin pregnancy rate of IVF is 20 times higher than that 
of natural childbirth. Twins will cause greater intrauterine 
pressure on the mother uterus. At the same time, nutri-
tional needs have also increased, resulting in premature 
DOI: https://doi.org/10.30564/jams.v2i2.509
17
Journal of Advances in Medicine Science | Volume 02 | Issue 02 | April 2019
Distributed under creative commons license 4.0
birth rate of IVF higher than that of natural delivery ba-
bies. Twins are an important cause of preterm birth, and 
preterm birth is the main cause of neonatal hyperbilirubin-
emia and low birth weight.
3.4 Neonatal Birth Defects
Neonatal birth defects refer to the embryos being affected 
by adverse factors during the process of gestation, result-
ing in congenital physiological structural malformations 
or disorders and systemic disorders in the development of 
normal embryos.[7] Congenital birth defects are not only 
indicative of birth babies, but also natural abortions and 
stillbirths. Relevant surveys have shown that pregnant 
women who use IVF technology have a 20% to 30% 
higher risk of spontaneous abortion than women with 
natural pregnancy, which is related to the relatively large 
age of IVF women. According to the analysis of the fol-
low-up data of the IVF infants born in our hospital, the 
total birth defect rate of IVF was 0.88%, and the incidence 
of congenital heart disease was 0.23%. In recent years, 
the incidence of birth defects in infants born with natural 
pregnancy has increased from 0.86% in 1995 to 2.08% in 
2004. The incidence of congenital heart disease in natural 
gestational infants is 0.8% to 1.3%, indicating that the 
application of IVF technology does not increase the inci-
dence of neonatal birth defects.[8]
3.5 Neonatal Complications
According to the comparative analysis of IVF and nat-
ural delivery babies in our hospital, it is concluded that 
the complications of venous respiratory system, sepsis, 
neonatal anemia and jaundice and the mortality rate are 
higher than those of natural delivery babies. However, 
after the twins were excluded, the perinatal complications 
of IVF were similar to those of natural delivery babies. At 
the same time, during the investigation, it was found that 
neonatal complications were closely related to the age of 
the pregnant woman, the gestational age and whether the 
pregnant woman had pregnancy-induced hypertension. At 
present, many scholars blame the neonatal complications 
on neonatal premature birth, twins, and pregnancy-in-
duced hypertension. Both premature birth and pregnan-
cy-induced hypertension are associated with twins, and it 
can be considered that reducing twin pregnancies signi -
cantly reduces the incidence of neonatal complications. 
In addition, if the twin-pregnant women can get adequate 
nutrition guarantee during pregnancy, and receive the sys-
tem of pregnancy care and prenatal examination, timely 
give the lung-promoting medicine before the premature 
delivery, which can effectively avoid respiratory diseas-
es caused by neonatal lung hypoplasia, thus effectively 
reducing the incidence of death and asphyxia caused by 
complications.[9] Therefore, improving the perinatal nu-
trition supply and obstetric care of pregnant women and 
women is an important prerequisite for reducing the com-
plication rate and mortality of newborns.
4. Conclusion
IVF technology has gone through four generations of 
technology since its inception, and it has been repeatedly 
questioned by various circles in the development process. 
Only strengthen the research and development of IVF 
technology, strictly control the indications of IVF, im-
prove the quality of embryo culture in vitro, and reduce 
the rate of multiple pregnancies as much as possible, so as 
to effectively improve the fertility quality of IVF, promote 
family happiness, social stability and national prosperity.
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